CN104623660B - Application of copper-doped gold nanorods in preparation of antitumor drugs - Google Patents

Application of copper-doped gold nanorods in preparation of antitumor drugs Download PDF

Info

Publication number
CN104623660B
CN104623660B CN201510031636.7A CN201510031636A CN104623660B CN 104623660 B CN104623660 B CN 104623660B CN 201510031636 A CN201510031636 A CN 201510031636A CN 104623660 B CN104623660 B CN 104623660B
Authority
CN
China
Prior art keywords
copper
gold nanorods
gnr
cell
doped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510031636.7A
Other languages
Chinese (zh)
Other versions
CN104623660A (en
Inventor
铁绍龙
兰胜
范海华
乐琼
梁杰霞
刘露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Clusterbiophoton Tech Co Ltd
Original Assignee
Guangzhou Clusterbiophoton Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Clusterbiophoton Tech Co Ltd filed Critical Guangzhou Clusterbiophoton Tech Co Ltd
Priority to CN201510031636.7A priority Critical patent/CN104623660B/en
Publication of CN104623660A publication Critical patent/CN104623660A/en
Application granted granted Critical
Publication of CN104623660B publication Critical patent/CN104623660B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses an application of copper-doped gold nanorods in preparation of antitumor drugs. Studies of inventors show that copper-doped gold nanorods are converted into 2-5nm small-sized gold quantum dots under high-power ultrasound action and then selectively kill tumour cells, therefore, the copper-doped gold nanorods can be used as an online antitumor preparation for treating various cancers and the irradiation time of HIFU (high intensity focused ultrasound) can be shortened.

Description

Application of the gold nanorods of copper doped in antitumor drug is prepared
Technical field
The present invention relates to a kind of new application of nano material, the more particularly to gold nanorods of copper doped are preparing antineoplastic agent Answering in thing.
Background technology
Worldwide, cancer has become " first killer " of the mankind.World Health Organization (WHO)(WHO)Statistical data (2012)Show, cancer causes 8,200,000 people dead.In following 20 years, estimate annual cases of cancer by by 1400 in 2012 Ten thousand rise to 22,000,000.The annual newfound cancer patient of China brings huge bearing more than 1,000,000 to patient and society Load.
At present, treatment of the modern medicine to cancer is mainly operative treatment and coordinates Radiotherapy chemotherapy, part simultaneously using targeting or Genomic medicine, is equipped with response Chinese traditional treatment and improves curative effect;For local or early-stage cancer, considerable part is poly- using laser or ultrasound Burnt or alternation magnetic resonance thermotherapy treatment partial malignancy, or local operation.Though local operation can remove most of protopathy Stove, but can not fundamentally prevent the regeneration and breeding of cancerous cell;Though Radiotherapy chemotherapy can kill cancerous cell, while also making a large amount of Suffer damage including normal immunological histiocyte, induce bad gastrointestinal reaction, bone marrow depression and Liver and kidney, impairment of cardiac function, make The body of patient is weaker, and resist the disease is greatly lowered with anti-infection ability, and majority is suffered from carninomatosis people and is difficult to successfully control Treat or extend life cycle.
There are some researches show, the small size nano gold spherical of diameter 5 or 20nm is natural with good active anticancer (Rochelle R. Arvizo et al, Inhibition of tumor growth and metastasis by a Self-therapeutic nanoparticle, PNAS, 2013,110 (17): 176700–6705), it is capable of achieving contracting within 3 days It is little by 70~80%.But cancerous cell is low to the uptake ratio of gold nanosphere, cause its fragmentation effect not fully up to expectations.
Gold nanorods(Gold Nanorod, GNR)Itself is nontoxic, the characteristic with near-infrared laser response, can be used to swash Photo-thermal therapy cancer, its weak point be gold nanorods easily because heat realize baseball change, cause its with near-infrared laser respond Characteristic dies down and even disappear.And gold nanorods are changed into the oversized of gold nanosphere, also there is no anti-tumor activity.
The gold nanorods of copper doped are in the preparation process of gold nanorods, to be prepared by adding monovalence or bivalent cupric ion A kind of new gold nanorods for obtaining, not there are some researches show that it has anti-tumor activity.
The content of the invention
It is an object of the invention to provide application of the gold nanorods of copper doped in antitumor drug is prepared.
Further object is that providing the anti-tumor agent that a kind of ultrasonic wave added treats tumor.
It is yet a further object of the present invention to provide a kind of preparation technology of gold nanosphere.
Inventor's research finds that the gold nanorods of copper doped can be converted into 2~5nm under the ultrasonication of higher-wattage Small size gold quantum dot, so selective killing tumor cell and to normal cell basic nonhazardouss effect, improve patient's immunity Ability.Experimental data shows that the gold nanorods of copper doped add the culture 48 of system containing hepatoma carcinoma cell little after supersound process When, it acts on hepatoma carcinoma cell causes hepatoma carcinoma cell death more than 70%.The PEG of the gold nanorods of copper doped(Polyethylene Glycol, Polyethylene Glycol)Dispersion liquid can be cultivated directly together with cancerous cell, in high intensity focused ultrasound(More than 1000W/cm2) Under irradiation, that is, the strong golden quantum dot of 2~5nm small sizes, active anticancer is converted into, focuses on ultrasonic pyrogenicity and act on golden quantum dot Under the dual function of cancerous cell, accelerate cancer cell death.Therefore this copper-golden nanometer rod of mixing can be used for as online anticancer preparation Various cancers are treated, shortens HIFU(High Intensity Focused Ultrasound high intensity focused ultrasounds)During irradiation Between.
Description of the drawings
Fig. 1 is the UV-Vis abosrption spectrograms for mixing copper GNR(a), TEM figure(b);
Fig. 2 is the scattered TEM figures for mixing copper GNR gained dispersion liquids Jing after 300W ordinary ultrasonics instrument acts on 20min of PEG;
Fig. 3 is the scattered TEM figures for mixing copper GNR Jing after different high intensity focused ultrasound devices are processed of PEG;
Fig. 4 is different draw ratios(Aspect Ratio, AR)The UV-Vis delustring spectrograms of PEG-GNR dispersion liquids;
Fig. 5 is impact figure of the different draw ratio PEG-GNR dispersion liquids incubations to hepatocellular carcinoma H22 cytoactive;
Fig. 6 be PEG- mix copper GNR dispersion liquids incubate Jing after different capacity supersound process to hepatocellular carcinoma H22 cell live The impact figure of property;
Fig. 7 is different disposal to normal cell L02 and the impact figure of hepatocellular carcinoma H22 activity.
Specific embodiment
Conveniently to see, in the present invention, the gold nanorods for mixing copper are abbreviated as mixing copper GNR.
The gold nanorods of copper doped are preparing the application of antitumor drug.
In the gold nanorods of copper doped, the quality doping of copper is 0.5%~0.01%, further, the quality doping of copper Measure as 0.2%~0.05%.
For the ease of target tumor, being coupled on the gold nanorods of copper doped has cancer target agent.Cancer target agent is preferably Cancer target polypeptide.
In order to be beneficial to cellular uptake GNR, draw ratio AR of the gold nanorods of copper doped is more than 1.5.In view of preparation work The complexity of skill, AR values are preferably 3~8.
The copper GNR that mixes of minor diameter is easier to be converted into gold nanosphere under ultrasonication, test result indicate that, diameter exists 20nm or following mix copper GNR in the presence of ultrasound can with higher rate conversion as gold nanosphere, but minor diameter GNR have higher conversion ratio, consider, the diameter of gold nanorods is preferably 5~8nm.
A kind of anti-tumor agent, the gold nanorods containing copper doped.
In the gold nanorods of copper doped, the quality doping of copper is 0.5%~0.01%, further, the quality doping of copper Measure as 0.2%~0.05%.
A kind of preparation technology of golden quantum dot, including:The gold nanorods of copper doped are dispersed in dispersant, are carried out afterwards Supersound process, obtains golden quantum dot.
In the gold nanorods of copper doped, the quality doping of copper is 0.5%~0.01%, further, the quality doping of copper Measure as 0.2%~0.05%.
Mix the preparation of copper GNR
Mixing copper GNR can be using crystal seed method, such as document Xingchen Ye et al, Improved Size-Tunable Synthesis of Monodisperse Gold Nanorods through the Use of Aromatic Additives, ACS nano 2012,6 (3):Method disclosed in 2804-2817 is prepared;Non- crystal seed can also be adopted Method, the method as disclosed in inventor is in CN 103203459A is prepared.
For the sake of convenient, the example that copper GNR is mixed in present invention preparation is as follows with method:
5mL 0.1M CTAB are taken in 25mL beakers, 500 μ L chlorauric acid solutions are added toward beaker, added again in stirring Enter 32.5 μ L silver nitrate solutions, 50 μ L ascorbic acid solutions, stir, add 3 μ L sodium borohydride solutions, proceed to 30 DEG C of water Water-bath 11min in bath, adds 5mL deionized waters, 32.5 μ L silver nitrate solutions in stirring, add 5 μ L 0.1M CuCl Dispersion liquid, proceeds to 22 DEG C of cooling circulating slot growth 24h.It is distributed to that to obtain final product PEG in PEG solution scattered after centrifugation, cleaning Mix copper GNR solution.
What the method was prepared mixes UV-Vis absorption spectrums such as Fig. 1 of copper GNR(a)It is shown, its TEM figure such as Fig. 1(b) It is shown.It is 0.1% that fluorimetry measures wherein copper content.By the consumption for changing CuCl dispersion liquids or other cupric predecessors Or concentration is capable of achieving to mix amount of copper in GNR.
Mix the supersound process characteristic of copper GNR:
Take 500 μ L optical density (OD)s(OD)Copper GNR is mixed for 4(LSPR=803nm, copper content 0.1%, similarly hereinafter)PEG disperses Liquid, in being put into common 300W, 50Hz Ultrasound Instrument, ultrasonic 20min.
The TEM figures for mixing copper GNR before and after sonicated are respectively such as Fig. 1(b), shown in Fig. 2, Fig. 2(a)In, the upper left corner Illustration is the TEM pictures after the supersound process amplified, and remainder is the TEM figures after processing.From Fig. 2(a)In it can also be seen that After mixing the supersound process of copper GNR Jing higher-wattages, 2~5nm gold quantum dots are converted into.And to undoped p under the same terms GNR carries out supersound process, and the pattern of gold nanorods does not occur visible change.
It is further test result indicate that, when the quality doping of copper is 0.5%~0.01%, mixing copper GNR can be super Golden quantum dot is converted in the presence of sound.When the quality doping of copper is 0.2%~0.05%, when more preferably 0.1%, copper GNR is mixed Preferably sonicated can be converted into golden quantum dot.Fig. 2(b)Give that to mix the dispersion liquid Jing that copper mass is 0.01% common The TEM figures of 300W, 50Hz Ultrasound Instrument ultrasound 20min.
Mix the HIFU process of copper GNR
Take 500 μ L optical density (OD)s(OD)For the GNR for mixing copper 0.1% of 4 PEG modifications(LSPR=800nm)Dispersion liquid, puts In entering 5mL PP pipes, the JC type focusing ultrasound tumor treating systems that Chong Qinghai helps company to produce are inserted, select frequency 1.4MHz, it is burnt Domain meansigma methodss:1.2mm;Focal length 135mm;The W of power 220, action time 2 min, gained dispersion liquid is golden quantum dot.Equally, adopt The type high-intensity focus supersonic tumor treatment systems of HIFU 1 produced with Xin Di industrial corporations of Shanghai Communications University, focus power control System is in 1200W/cm2, irradiation 1min, gained dispersion liquid also switchs to golden quantum dot.Fig. 3 sets forth its TEM figure(A, b).Can To find out, due to focussing force, the golden quantum dot that copper GNR is converted into quickly at short notice irregular, a diameter of 2~5nm is mixed.
Mix the antitumor action of copper GNR
The application for mixing copper GNR in anticancer aspect of the present invention is expanded on further below by way of experiment.
The PEG dispersion liquids of GNR are abbreviated as PEG-GNR.
Mtt assay main process in the following example is as follows:
1) logarithmic (log) phase cell is collected, adjusts concentration of cell suspension, add 100 ml, bed board to make cell to be measured adjust density per hole To 5000/ hole,(Edge hole is filled with aseptic PBS);
2)5%CO2, 37 DEG C are incubated, and to cell monolayer bottom hole is paved with(96 hole flat undersides), 12h is cultivated, after cell attachment, When growth conditions are good, remove old culture fluid, take out with containing/or without, Jing/or not sonicated setting concentration Mix copper/or do not mix copper-golden nanometer rod(Pollution is prevented before PEG-GNR uses with ultra-vioket radiation sterilization 30min)Culture fluid The cell of culture certain hour, per the μ l of hole 100, if 5 multiple holes;
3) continue in 5%CO2, certain hour is incubated under the conditions of 37 DEG C, observe under inverted microscope;
4) culture plate is taken out, 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) is added per hole, continue to cultivate 4h;
5) terminate culture, carefully suck culture fluid in hole;
6) 150 μ l dimethyl sulfoxide are added per hole, the min of low-speed oscillation 10 on shaking table is put, crystal is fully dissolved, The light absorption value in each hole is measured at enzyme-linked immunosorbent assay instrument OD 490nm;
7) while it is blank group to arrange zeroing hole(Culture fluid, MTT, dimethyl sulfoxide), control wells(Cell, same concentrations GNRs dissolving medium PEG, culture fluid, MTT, dimethyl sulfoxide);
8) interpretation of result:Survivaling cell %=(OD experimental group-OD blank groups)/(OD compares-OD blank groups)×100%.
If not specializing below, copper GNR copper contents of mixing used represent gold nano grain for 0.1%, GNP(Gold Nanoparticle).
The cytotoxicity of undoped p GNR dispersion liquid
Cell is the hepatoma Hep G 2 cells for cultivating, and period adds Jing 300W Ultrasound Instrument ultrasound 30min, different draw ratios (its UV-Vis Spectral Extinction is as shown in Figure 4 for PEG-GNR dispersion liquids)So as to middle concentration be 12.5,25,37.5,50nM, observation temperature The activity of hepatocellular carcinoma H22 after 24h, 36h is educated, as a result such as Fig. 5(A, b).As a result show, different draw ratios it is unadulterated GNR cytotoxicities are more or less the same, consistent with the result that document discloses report to the basic avirulence of hepatoma Hep G 2 cells.
PEG- mixes the cytotoxicity of copper GNR dispersion liquids after supersound process
Using mtt assay, first the copper PEG-GNR different capacity ordinary ultrasonics instrument of mixing that draw ratio is 4.7 is disperseed into 30min, The relation of re-test hepatoma Hep G 2 cells activity vs. concentration and incubative time.As a result such as Fig. 6.Fig. 6 results show, with 100 To the almost non-toxic difference of cancerous cell after W is ultrasonic, after 300 W ultrasound 30min, mix copper GNR dispersion liquids has aobvious to hepatoma Hep G 2 cells Write toxicity;And, this toxicity mixes the concentration of copper GNR dispersion liquids, cultivation time with addition PEG- to be increased and enhancing, 48h(2d) Afterwards, hepatoma Hep G 2 cells activity is reduced to 10%.Thus illustrate, it is high-power that PEG- mixes copper GNR dispersion liquid Jing(300W)It is common super After sound, active anticancer strengthens, and has persistence to hepatoma Hep G 2 cells toxicity, and it is special that hint mixes copper GNR Jing after large power supersonic Property is significantly changed;And low-power(100 usual W of laboratory)Ultrasound Instrument ultrasound same time, almost without cell Toxicity, implies that the pattern for now mixing copper GNR has no and significantly changes.
Copper GNR is mixed under high-power ultrasonic effect to normal cell L02 and hepatoma Hep G 2 cells using mtt assay research Toxicity, addition mixed in the test group of copper GNR, and the concentration for mixing copper GNR is 250 nM, as follows under packet and disposition:
First group of cell:Matched group, without the culture fluid culture 72 hours for mixing copper GNR and not through supersound process;
Second group of cell:Merely through the ultrasonic Treatment 15 minutes of 300W;
3rd group of cell:The culture fluid culture 72 hours of copper GNR is mixed only with addition, not through supersound process;
4th group of cell:After the culture fluid culture 72 hours of copper GNR is first mixed using addition, the culture for mixing copper GNR will be contained Liquid is removed, and is substituted with the culture fluid without GNR, then through 300W ultrasonic Treatment 15 minutes;
5th group of cell:After the culture fluid culture 72 hours of copper GNR is first mixed using addition, culture fluid is directly super using 300W Sonicated 15 minutes.
Experimental result is as shown in Figure 7.It is specific as follows:
In second group of cell, the survival rate of two kinds of cells drops to respectively 86.9% and 84.5%, shows high-power ultrasonic Cell is deposited with certain damage, but affect difference unobvious;
In 3rd group of cell, the survival rate of two kinds of cells is respectively 74% and 75%, and the two difference is not also obvious.Because culture The concentration that copper GNR is mixed in liquid has reached 250 nM, therefore has certain toxicity to cell;
In 4th group of cell, the survival rate of two kinds of cells is down to respectively 44.3% and 57%.
In 5th group of cell, the survival rate of two kinds of cells is down to respectively 21% and 41%.
Interpretation of result:
In fact, high-power ultrasonic and high concentration are mixed, impacts of the copper GNR to hepatoma carcinoma cell survival rate is estimated should to be 86.9%´74%=64.3%.However, carrying out ultrasonic Treatment again after we allow cellular uptake to mix copper GNR, the survival of cell is found Rate only has 44.3%(Remove containing the culture fluid for mixing copper GNR before ultrasonic Treatment)With 21%(Retain to contain before ultrasonic Treatment and mix copper GNR Culture fluid), illustrate to mix small size GNP that copper GNR is transformed under high-power ultrasonic effect cell is generated it is certain Toxicity.Because the intake of cell is limited, therefore the former survival rate of cell is greater than the latter.
For normal liver cell, it is pre- that high-power ultrasonic and high concentration mix impacts of the copper GNR to hepatoma carcinoma cell survival rate Meter should be 84.5% 75%=63.4%.However, carrying out ultrasonic Treatment again after we allow cellular uptake to mix copper GNR, find thin The survival rate of born of the same parents is 57.1%(Remove containing the culture fluid for mixing copper GNR before ultrasonic Treatment)With 41%(Retain before ultrasonic Treatment and contain Mix the culture fluid of copper GNR), also explanation mixes copper GNR small sizes GNP for being transformed under high-power ultrasonic effect and cell produced Certain toxicity.
As can be seen that in the case where the collective effect of copper GNR and high-power ultrasonic is mixed, the survival rate of normal liver cell will More than the survival rate of hepatoma carcinoma cell, particularly when without the culture fluid containing GNR is removed, illustrate that normal liver cell has certain Self-repair function.Research before shows that GNR can be excluded body by normal cell after intake GNR through a period of time Outward.Therefore, the GNR negligible amounts in normal cell are remained in so that under ul-trasonic irradiation produce GNP quantity also compared with Little, the impact to cell survival rate is also just substantially little than hepatoma carcinoma cell.

Claims (6)

1. application of the gold nanorods of copper doped in antitumor drug is prepared, wherein, in the gold nanorods of copper doped, the matter of copper Amount doping is 0.01%~0.5%, and the draw ratio of gold nanorods is more than 1.5, a diameter of 5~8nm of gold nanorods.
2. application according to claim 1, it is characterised in that:In the gold nanorods of copper doped, the quality doping of copper is 0.05%~0.2%.
3. application according to claim 1 and 2, it is characterised in that:Being coupled on gold nanorods has cancer target agent.
4. a kind of preparation technology of golden quantum dot, including:The gold nanorods of copper doped are dispersed in dispersant, are surpassed afterwards Sonication, obtains golden quantum dot;Wherein, in the gold nanorods of copper doped, the quality doping of copper is 0.01%~0.5%, Jenner The draw ratio of rice rod is more than 1.5, a diameter of 5~8nm of gold nanorods.
5. preparation technology according to claim 4, it is characterised in that:In the gold nanorods of copper doped, the quality doping of copper Measure as 0.2%~0.05%.
6. a kind of anti-tumor agent, it is characterised in that:Gold nanorods containing copper doped in the preparation;Wherein, copper doped In gold nanorods, the quality doping of copper is 0.01%~0.5%, and the draw ratio of gold nanorods is more than 1.5, gold nanorods it is straight Footpath is 5~8nm.
CN201510031636.7A 2015-01-21 2015-01-21 Application of copper-doped gold nanorods in preparation of antitumor drugs Active CN104623660B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510031636.7A CN104623660B (en) 2015-01-21 2015-01-21 Application of copper-doped gold nanorods in preparation of antitumor drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510031636.7A CN104623660B (en) 2015-01-21 2015-01-21 Application of copper-doped gold nanorods in preparation of antitumor drugs

Publications (2)

Publication Number Publication Date
CN104623660A CN104623660A (en) 2015-05-20
CN104623660B true CN104623660B (en) 2017-05-17

Family

ID=53203214

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510031636.7A Active CN104623660B (en) 2015-01-21 2015-01-21 Application of copper-doped gold nanorods in preparation of antitumor drugs

Country Status (1)

Country Link
CN (1) CN104623660B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105535978A (en) * 2016-01-30 2016-05-04 新乡医学院第一附属医院 Tumor stem cell optional killing agent and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104043123A (en) * 2007-01-25 2014-09-17 达娜-法勃肿瘤研究所公司 Use Of Anti-egfr Antibodies In Treatment Of Egfr Mutant Mediated Disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104043123A (en) * 2007-01-25 2014-09-17 达娜-法勃肿瘤研究所公司 Use Of Anti-egfr Antibodies In Treatment Of Egfr Mutant Mediated Disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A Seed-Based Diffusion Route to Monodisperse Intermetallic CuAu Nanocrystals;Wei Chen,et al;《Nanoparticles》;20100315;第49卷(第16期);第2917-2921页 *

Also Published As

Publication number Publication date
CN104623660A (en) 2015-05-20

Similar Documents

Publication Publication Date Title
Yu et al. Black hollow silicon oxide nanoparticles as highly efficient photothermal agents in the second near-infrared window for in vivo cancer therapy
Shashkov et al. Quantum dots as multimodal photoacoustic and photothermal contrast agents
Karagianni et al. Application of carbon-based quantum dots in photodynamic therapy
Sun et al. Nitrogen-doped graphene quantum dots coupled with photosensitizers for one-/two-photon activated photodynamic therapy based on a FRET mechanism
Ma et al. Platinum nanoworms for imaging-guided combined cancer therapy in the second near-infrared window
CN101732720B (en) Preparation and application of anti-cancer medicament carrier with dual functions of targeting and fluorescence
CN108187046A (en) A kind of metal organic frame of modified hyaluronic acid masking, nano-particle, nano-particle preparation method and applications
Zhao et al. Gold nanorods based multicompartment mesoporous silica composites as bioagents for highly efficient photothermal therapy
CN105412926A (en) Polyethylene glycol modified Bi nano photothermal conversion material as well as preparation method and application thereof
Yan et al. Second Near‐Infrared Plasmonic Nanomaterials for Photoacoustic Imaging and Photothermal Therapy
CN109620816A (en) A kind of nano immune preparation and the preparation method and application thereof
Huang et al. Radar-like MoS 2 nanoparticles as a highly efficient 808 nm laser-induced photothermal agent for cancer therapy
CN104623660B (en) Application of copper-doped gold nanorods in preparation of antitumor drugs
Qian et al. NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy
CN103273080A (en) Nanometer golden flower and preparation method and application of nanometer golden flower
CN106753344A (en) Silver sulfide quantum dot and preparation method and application
CN106882791B (en) The preparation method and applications of water dispersible carbon nano-onions
He et al. Polymyxin E biomineralized and doxorubicin-loaded gold nanoflowers nanodrug for chemo-photothermal therapy
CN113304264B (en) Quercetin tellurium nanoparticles and preparation method thereof
Lv et al. Absorption-dependent generation of singlet oxygen from gold bipyramids excited under low power density
CN102284063A (en) Application of carbon nanotube-chitosan-phycocyanin compound in preparing antineoplastic drugs
CN107625962B (en) PEG-modified two-dimensional nanosheet photo-thermal conversion material and application thereof
Abdulla-Al-Mamun et al. Plasmon-induced photothermal cell-killing effect of gold colloidal nanoparticles on epithelial carcinoma cells
CN106310260A (en) Preparation method and application of BSA-CuS nanocomposite material
Li et al. Two-photon fluorescence-guided precise photothermal therapy located in a single cancer cell utilizing bifunctional N-doped carbon quantum dots

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Application of copper-doped gold nanorods in preparation of antitumor drugs

Effective date of registration: 20200715

Granted publication date: 20170517

Pledgee: Bank of Guangzhou branch of the Bank of Guangzhou Science City Branch

Pledgor: GUANGZHOU CLUSTERBIOPHOTON TECH Co.,Ltd.

Registration number: Y2020440000191

PP01 Preservation of patent right
PP01 Preservation of patent right

Effective date of registration: 20211122

Granted publication date: 20170517